Removal of micropollutants in WWTP effluent by biological assisted membrane carbon filtration (BioMAC)

Water Science and Technology

Volumn 63, Issue 1, 2011, Pages 72-79

  Weemaes, M ^a   Fink, G ^b   Lachmund, C ^b   Magdeburg, A ^c   Stalter, D ^c   Thoeye, C ^a   De Gueldre, G ^a   Van De Steene, B ^a  

^a Aquafin Belgium   (Belgium)

^b FEDERAL INSTITUTE OF HYDROLOGY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

GAC; ICM; Micropollutants; Pharmaceuticals; Ultrafiltration; WWTP effluent

Indexed keywords

GAC; ICM; MICROPOLLUTANTS; PHARMACEUTICALS; WWTP EFFLUENT;

ACTIVATED CARBON; BIOFILTRATION; CONTRAST MEDIA; MICROFILTRATION; REMOVAL; ULTRAFILTRATION;

ANTIBIOTICS;

ACTIVATED CARBON; ANDROGEN; ANTIBIOTIC AGENT; IODINATED CONTRAST MEDIUM; STEROID;

ACTIVATED CARBON; ANTIBIOTICS; DRUG; GRANULAR MEDIUM; MEMBRANE; POLLUTANT REMOVAL; STEROID; ULTRAFILTRATION; WASTE TREATMENT;

ACIDITY; ARTICLE; ECOTOXICITY; ESTROGEN ACTIVITY; SAND; ULTRAFILTRATION; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER POLLUTANT;

CARBON; MEMBRANES, ARTIFICIAL; PILOT PROJECTS; ULTRAFILTRATION; WATER POLLUTANTS;

EID: 79251485668     PISSN: 02731223     EISSN: None     Source Type: Journal    
DOI: 10.2166/wst.2011.011     Document Type: Article

References (22)

1. Castiglioni, S., Bagnati, R., Fanelli, R., Pomati, F., Calamari, D. & Zucato, E. 2006 Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 40, 357-363.
2. Clara, M., Kreuzinger, N., Strenn, B., Gans, O. & Kroiss, H. 2005 The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res. 39(1), 97-106. (Pubitemid 40021770)
3. De Wilde, W., Besançon, A., Joss, A., Sharma, S., Pollice, A., Kazner, C., Ernst, M., Xuan, Z. & How Yong Ng. 2007 EU FP6 Project Reclaim Water (Contract-No 018309) Deliverable D 1.1 : Characterisation of unit operations for wastewater reclamation in terms of upgrading capability, reliability and flexibility.
4. Göbel, A., McArdell, C., Joss, A., Siegrist, H. & Giger, W. 2007 Fate of sulfonamides, macrolides and trimethoprim in different wastewater tratment technologies. Sci. Total Environ. 372, 361-371.
5. Jobling, S., Burn, R. W., Thorpe, K., Williams, R. & Tyler, C. 2009 Statistical modeling suggests that antiandrogens in effluents from wastewater treatment works contribute to widespread sexual disruption in fish living in english rivers. Environ. Health Perspectives 17(5), 797-802.
6. Joss, A., Siegrist, H. & Ternes, T. A. 2008 Are we about to upgrade wastewater treatment for removing organic micropollutants? Water Sci. Technol. 57(2), 251-255.
7. Lachmund, C., Magdeburg, M., Oehlmann, J., Schulte-Oehlmann, U. & Stalter, D. 2007 EU FP6 project Neptune (Contract-No. 036845) Deliverable D 3.1:Ecotoxicity and microbiological testing methods (OECD and DIN/ISO guidelines) optimized for whole effluent testing.
8. Lishman, L., Smyth, S. A., Sarafin, K., Kleywegt, S., Toito, J., Peart, T., Lee, B., Servos, M., Beland, M. & Seto, P. 2006 Occurence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci. Total Environ. 367, 544-558.
9. Oehlmann, J., Di Benedetto, P., Tillman, M., Duft, M., Oetken, M. & Schulte-Oehlmann, U. 2007 Endocrine disruption in prosobranch molluscs: evidence and ecological relevance. Ecotoxicology 16(1), 29-43. (Pubitemid 46292041)
10. Okuda, T., Kobayashi, Y., Nagao, R., Yamashita, N., Tanaka, H., Tanaka, S., Fujii, S., Konishi, C. & Houwa, I. 2008 Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan. Water Sci. Techonol. 57(1), 65-71.
11. Routledge, E. J. & Sumpter, J. P. 1996 Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ. Toxicol. Chem. 15(3), 241-248.
12. Reungoat, J., Macova, M., Escher, B. I., Carswell, S., Mueller, J. F. & Keller, J. 2010 Removal o f micropollutants and reduction of biological activity in a full scale reclamation plant using ozonation and activated carbon filtration. Water Res. 44(2), 625-637.
13. Schulz, M., Loffler, D., Wagner, M. & Ternes, T. A. 2008 Transformation of the X-ray contrast medium Iopromide in soil and biological wastewater treatment. Environ. Sci. Technol. 42(19), 7207-7217.
14. Snyder, S., Adham, S., Redding, A., Cannon, F., DeCarolis, J., Oppenheimer, J., Wert, E. & Yoon, Y. 2007 Role of memebranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202, 156-181. (Pubitemid 44829082)
15. Stalter, D., Magdeburg, A., Weil, M., Knacker, T., Oehlmann, J. 2010a Toxication or Detoxication? In-vivo toxicity assessment of ozonation as advanced wastewater treatment with the rainbow trout. Water Res. 44(2), 439-448.
16. Stalter, D., Magdeburg, A. & Oehlman, J. 2010b Comparative toxicity assessment of ozone and activated carbon treated sewage effluents using an in vivo test battery. Water Res. 44(8), 2610-2620.
17. Ternes, T. A. & Joss, A. 2006 Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management. London, IWA Publishing.
18. Van Hege, K., Dewettinck, T., Claeys, T., De Smedt, G. & Verstraete, W. 2002 Reclamation of treated domestic wastewater using biological assisted membrane carbon filtration (BioMAC). Environ. Technol. 23(9), 971-980.
19. Wagner, M. & Oehlmann, J. 2009 Endocrine disruptors in bottled mineral water: Total estrogenic burden and migration from plastic bottles. Environ. Sci. Pollut. Res. 16(3), 278-286.
20. Wick, A., Fink, G., Joss, A., Siegrist, H.& Ternes, T. A. 2009 Fate of beta blockers and psycho-active drugs in conventional wastewater treatment. Water Res. 43(4), 1060-1074.
21. Yu, J., Bouwer, E. & Coelhan, M. 2006 Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agri. Water Man. 86, 72-80.
22. Yu, Z. R., Peldzus, S. & Huck, P. M. 2008 Adsorption characteristics of selected pharmaceuticals and an endocrine disrupting compound - Naproxen, carbamazepine and nonylphenol - on activated carbon. Water Res. 42(12), 2873-2882.